Device Firms Capitalize On Booming Chinese Market, Face Price Hurdles
This article was originally published in PharmAsia News
Executive Summary
According to Zero2IPO, China’s medical device company M&As totaled nine in number and involved disclosed amounts totaling RMB 8.37 billion ($134.25 million) in 2012.